Abstract
Worldwide, coronary heart disease (CHD) and stroke are the first and second leading causes of death, major contributors to disability, and the most common conditions – following hypertension or high blood pressure – comprising the cardiovascular diseases (CVDs) (Mazzati et al. 2006). Together these conditions rank among the foremost public health challenges of our time. They have been under extensive epidemiological investigation for more than a half century. As a result, with parallel clinical and laboratory research, understanding of the causation and means of prevention of CVDs have become well established. Their present and future global impact is becoming recognized. Calls for action to prevent heart disease and stroke are widespread at national and global levels (Labarthe 2011).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
1 DALY lost = 1 full year of life expectancy lost, 2 years lived with 50% disability, etc.
References
Advisory Committee to the Surgeon General of the Public Health Service (1964) Smoking and health: report of the Advisory Committee to the Surgeon General. Public Health Service, US Department of Health, Education and Welfare, Atlanta, GA
Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O’Donnell CJ (2007) Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115:2878–2901
Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R (2007) Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco abuse. Lancet 370:2044–2053
Association of State and Territorial Directors of Health Promotion and Public Health Education (2001) Policy and environmental change: new directions for public health (executive summary). US Centers for Disease Control and Prevention, Atlanta, GA
Barker DJP (1998) Mothers, babies and health in later life, 2nd edn. Churchill Livingston, Edinburgh
Barker DJP (ed) (1992) Fetal and infant origins of adult disease. BMJ Books, London
Berenson GS (1986) Causation of cardiovascular risk factors in children: perspectives on cardiovascular risk in early life. Raven, New York
Berenson GS, Wattigney WA, Tracy RE, Newman WP III, Srinivasan SR, Webber LS, Dalferes ER Jr, Strong JP (1992) Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons ages 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol 70:851–858
Blackburn H (1983) Physical activity and coronary heart disease: a brief update and population view (Part I). J Card Rehabil 3:101–111
Blackburn H (1992) Community programs in coronary heart disease prevention and health promotion: changing community behaviour. In: Marmot M, Elliott P (eds) Coronary heart disease epidemiology: from aetiology to public health. Oxford University Press, Oxford, pp 495–514
Blackburn H (2012) Preventing heart attack and stroke. A history of cardiovascular epidemiology. http://www.epi.umn.edu/cvdepi/. Accessed on 18 July 2012
Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies: a classification system. Circulation 21:1160–1175
Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein A, Weinstein C (2011) The global economic burden of non-communicable diseases. World Economic Forum, Geneva
Boehm JK, Kubzansky LD (2012) The heart’s content: the association between positive psychological well-being and cardiovascular health. Psych Bull 138:655–691
Centers for Disease Control and Prevention (2007) Best practices for comprehensive tobacco control programs – 2007. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA
Chockalingam A, Balaguer-Vintró I (eds) (1999) Impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. Prous Science, Barcelona
Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, Robinson TN, Scott BJ, St. Jeor S, Williams CL (2005) Overweight in children and adolescents. Pathophysiology, consequences, prevention, and treatment. Circulation 111:1999–2012
Dawber TR, Meadors GF, Moore FE Jr (1951) Epidemiological approaches to heart disease: the Framingham study. Am J Public Health 41:279–286
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Siolber S, Thomsen T, Wood D (2003) Executive summary: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24:1601–1610
Diabetes Prevention Program Research Group (2002) Reduction in the incidence of T2DM with lifestyle intervention or metformin. N Engl J Med 346:393–403
Epstein FH (2005) Contribution of epidemiology to understanding coronary heart disease. In: Marmot M, Elliott P (eds) Coronary heart disease epidemiology. From aetiology to public health. Oxford University Press, Oxford, pp 8–17
Farquhar JW, Fortmann SP, Flora JA, Taylor B, Haskell WL, Williams PT, Maccoby N, Wood PD (1990) Effects of community wide education on cardiovascular disease risk factors: the Stanford Five-City Project. JAMA 264:359–365
Freis ED (1990) Reminiscences of the veterans administration trial of the treatment of hypertension. Hypertension 16:472–475
Glantz SA (2008) Meta-analysis of the effects of smokefree laws on acute myocardial infarction: an update (Letter). Prev Med 47:452–453
Goff DG, Howard G, Russell GB, Labarthe DR (2001) Birth cohort evidence of population influences on blood pressure in the United States, 1887–1994. Ann Epidemiol 11:271–279
Gordon T (1957) Mortality experience among the Japanese in the United States, Hawaii, and Japan. Public Health Rep 72:543–553
Guthold R, Ono T, Strong KL, Chatterji S, Morabia A (2008) Worldwide variability in physical inactivity. A 51-country survey. Am J Prev Med 34:486–494
Hill AB (1965) The environment and disease: association or causation? Proc Soc Med 58:295–300
Holman RL, McGill HC, Strong JP, Geer JC (1958) The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol 34:209–235
Hopkins PN, Williams RR (1981) A survey of 246 suggested coronary risk factors. Atherosclerosis 40:1–52
International Heart Health Society (2005) International action on cardiovascular disease: a platform for success based on international cardiovascular disease (CVD). Declarations. International Heart Health Society, Vancouver, Canada
International Obesity Task Force (2006) The Sydney Principles: guiding principles for achieving a substantial level of protection for children against the commercial promotion of foods and beverages. http://www.iotf.org/sydneyprinciples/index.asp. Accessed on 28 June 2009
INTERSALT Co-operative Research Group (1986) INTERSALT study: an international co-operative study on the relation of blood pressure to electrolyte excretion in populations. I: Design and methods. J Hypertens 4:781–787
IOM (Institute of Medicine) (2010a) Promoting cardiovascular health in the developing world: A critical challenge to achieve global health. The National Academies Press, Washington, DC
IOM (Institute of Medicine) (2010b) A population-based policy and systems change approach to prevent and control hypertension. The National Academies Press, Washington, DC
IOM (Institute of Medicine) (2010c) Strategies to reduce sodium intake in the United States. The National Academies Press, Washington, DC
Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P (eds) (2006) Disease control priorities in developing countries, 2nd edn. International Bank for Reconstruction and Development/The World Bank, Washington, DC
Kagan A, Yano K (1996) Ni-Hon-San Study. In: Kagan A (ed) The Honolulu heart program: an epidemiological study of coronary heart disease and stroke. Harwood Academic, Amsterdam, pp 21–32
Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J III (1961) Factors of risk in the development of coronary heart disease – six-year follow-up experience: the Framingham Study. Ann Intern Med 55:33–50
Keys A (1980) Seven Countries: a multivariate analysis of death and coronary heart disease. Harvard University Press, Cambridge, MA
Khoury MJ, Little J, Burke W (eds) (2004) Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease. Oxford University Press, Oxford
Koplan JP, Liverman CT, Kraak VI (eds) (2005) Preventing childhood obesity: Health in the balance. Committee on Prevention of Obesity in Children and Youth, Food and Nutrition Board, Board on Health Promotion and Disease Prevention, Institute of Medicine. The National Academies Press, Washington, DC
Labarthe DR (1998) Epidemiology and prevention of cardiovascular diseases: a global challenge. Aspen, Gaithersburg, MD
Labarthe DR (2011) Epidemiology and prevention of cardiovascular diseases: a global challenge, 2nd edn. Jones and Bartlett, Sudbury MA
Labarthe DR (2013) Cardiovascular health and disease. Oxford bibliographies in public health. McQueen, David V, Ed. New York: Oxford University Press. www.oxfordbibliographies.com
Labarthe DR, Dunbar SB (2012) Global cardiovascular health promotion and disease prevention: 2011 and beyond. Circulation 125:2667–2676
Labarthe DR, Khaw K-T, Thelle D, Poulter N (1998) The Ten Day International Teaching Seminars on Cardiovascular Epidemiology and Prevention: a 30-year perspective. CVD Prev 1:156–163
Leeder S, Raymond S, Greenberg H (2004) A race against time: the challenge of cardiovascular disease in developing countries. The Trustees of Columbia University in the City of New York, New York
Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PWF, Wolf PA, Levy D (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113:791–798
Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, and on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction. The American Heart Association’s strategic impact goal through 2020 and beyond. Circulation 121:586–613
Luepker RV, Evans A, McKeigue P, Reddy KS (2004) Cardiovascular survey methods. World Health Organization, Geneva
Mahoney LT, Lauer RM, Lee J, Clarke WR (1991) Factors affecting tracking of coronary heart disease risk factors in children. The Muscatine Study. Ann NY Acad Sci 623:120–132
Marmot M, Elliott P (eds) (2005) Coronary heart disease epidemiology: from aetiology to public health, 2nd edn. Oxford University Press, Oxford
Mason K, Chockalingam A, Prudhomme S, Stachenko S, Pearson T (2012) Policy Depot: a tool to build global capacity in cardiovascular health policy. Global Heart 7:47–51
Mazzati E, Vander Hoorn S, Lopez AD, Danaie G, Rodgers A, Mathers CD, Murray CJL (2006) Comparative quantification of mortality and burden of disease attributable to selected risk factors. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (eds) Global burden of disease and risk factors. The International Bank for Reconstruction and Development/ The World Bank, Washington, DC, pp 241–396
McCormick J, Skrabanek P (1988) Coronary heart disease is not preventable by population interventions. Lancet 2:839–841
Murray CJL, Lopez AD (eds) (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard School of Public Health, Boston
Narayan KMV, Williams D, Gregg EW, Cowie CC (2011) Diabetes public health: from data to policy. Oxford University Press, New York
National Forum for Heart Disease and Stroke Prevention (2012) www.nationalforum.org. Accessed on 18 Aug 2012
National Heart, Lung, and Blood Institute (2006) Incidence & prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Washington, DC
Olshansky SJ, Ault AB (1986) The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q 64:355–391
Omran AR (1971) The epidemiological transition: a theory of the epidemiology of population change. Milbank Q 49:509–538
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group (1990) Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA 264:3018–3024
Pearson TA, Jamison DT, Trejo-Gutierrez J (1993) Cardiovascular disease. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL (eds) Disease control priorities in developing countries. Oxford University Press, Oxford, pp 577–594
Poulter NR, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Rose G, Sever PS (1990) The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ 300:967–972
President’s Council on Physical Fitness and Sports (1996) Physical activity and health: a report of the Surgeon General. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA
Puska P (2002) Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland. Public Health Med 4:5–7
Puska P, Tuomilehto J, Nissinen A, Vartiainen E (eds) (1998) The North Karelia project: 20 year results and experiences. National Public Health Institute, KTL, Helsinki
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Roger VL, Turner MB on behalf of the American Heart Association Heart Disease and Stroke Statistics Writing Group (2011) Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation 123:e18–e209
Rose G (1981) Strategy of prevention: lessons from cardiovascular disease. BMJ 282:1847–1851
Rose G (1985) Sick individuals and sick populations. Int J Epidemiol 14:32–38
Rose GA, Blackburn H (1968) Cardiovascular survey methods. World Health Organization, Geneva
Rose G, Shipley M (1986) Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. BMJ 293:306–307
Sarti C, Stegmayr B, Tolonen H, Mahonen M, Tuomilehto J, Asplund K (2003) Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA project. Stroke 34(8):1833–1840
Sartwell PE (1959) On the methodology of investigations of etiologic factors in chronic diseases. Further comments. J Chron Dis 11:61–63
Sing CF, Haviland MB, Templeton AR, Zerba KE, Reilly SL (1992) Biological complexity and strategies for finding DNA variations responsible for inter-individual variation in risk of a common chronic disease, coronary artery disease. Ann Med 24:539–547
Stallones RA (1980) To advance epidemiology. Annu Rev Public Health 1:69–82
Stamler J (1992) Established major risk factors. In: Marmot M, Elliott P (eds) Coronary heart disease epidemiology: From aetiology to public health. Oxford University Press, Oxford, pp 35–66
Stamler J, Stamler R, Neaton JD, Wentworth W, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P (1999) Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282:2012–2018
Stehbens WE (1992) Causality in medical science with particular reference to heart disease and atherosclerosis. Perspect Biol Med 36:97–119
Strasser T (1978) Reflections on cardiovascular diseases. Interdiscip Sci Rev 3:225–230
Tejada C, Strong JP, Montenegro MR, Restrepo C, Solberg LA (1968) Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest 18:509–526
Thom TJ, Epstein FH, Feldman JJ, Leaverton PE, Wolz M (1992) Total mortality and mortality from heart disease, cancer and stroke from 1950 to 1987 in 27 countries: highlights of trends and their interrelationships among causes of death. NIH Publication 92–3088. National Heart, Lung and Blood Institute, National Institutes of Health, Public Health Service, US Department of Health and Human Services, Bethesda, MD
Tobacco Control (2012) 21 (2) March, 2012 (Entire issue)
Tunstall-Pedoe H (ed) (2003) MONICA monograph and multimedia source book. World Health Organization, Geneva
United Nations General Assembly (2011) Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Annex to A/66/L.1.United Nations General Assembly. New York, 16 September 2011. www.un.org/en/ga.. Accessed on 1 Oct 2011
US Department of Health and Human Services (2003) A public health action plan to prevent heart disease and stroke. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA
US Department of Health and Human Services (2006) The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA
Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P (1994) Changes in risk factors explain changes in mortality from ischemic heart disease in Finland. BMJ 309:23–27
Wolf-Maier K, Cooper RS, Banegas JR, Giampoli S, Hense H-W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzi D, Vescio F (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363–2369
World Health Organization (1992) International statistical classification of diseases and related health problems: tenth revision. World Health Organization, Geneva
World Health Organization (1999) Report by the Director-General: global strategy for the prevention and control of noncommunicable diseases. World Health Organization, Geneva
World Health Organization (2002) The world health report 2002: reducing risks, promoting healthy life. World Health Organization, Geneva. http://www.who.int/whr/2002/en/. Accessed on 18 Aug 2012
World Health Organization (2003) WHO framework convention on tobacco control. World Health Organization, Geneva
World Health Organization (2006) Commission on Social Determinants of Health. WHO/EPI/EQH/ 01/2006. World Health Organization, Geneva
World Health Organization (2007) Reducing salt intake in populations. Report of a WHO Forum and Technical Meeting 5–7 October 2006, Paris, France. World Health Organization, Geneva http://www.who.int/dietphysicalactivity/reducingsalt/. Accessed on 18 Aug 2012
World Health Organization (2008) Report on the global tobacco epidemic, 2008: The MPOWER Package. World Health Organization, Geneva
World Health Organization (2011) Non-communicable diseases country profiles. World Health Organization, Geneva
World Health Organization (2012) International Classification of Diseases (ICD) information sheet. www.who.int/classifications/icd/factsheet/en/. Accessed on 18 Aug 2012
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1996) Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicenter, case-control study. Lancet 348:505–510
World Health Organization Expert Committee (1990) Prevention in childhood and youth of adult cardiovascular diseases: time for action. WHO Technical Report Series 792. World Health Organization, Geneva
World Health Organization MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105–114
World Health Organization Study Group (1990) Diet, nutrition, and the prevention of chronic diseases. WHO Technical Report Series 797. World Health Organization, Geneva
World Heart Federation (2012) www.worldheart.org. Accessed on 18 Aug 2012
Yach D, Stuckler D, Brownell KD (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 1:62–66
Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and the impact of urbanization. Circulation 104:2746–2753
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Liu L on behalf of the INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Labarthe, D.R. (2014). Cardiovascular Health and Disease. In: Ahrens, W., Pigeot, I. (eds) Handbook of Epidemiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09834-0_35
Download citation
DOI: https://doi.org/10.1007/978-0-387-09834-0_35
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09833-3
Online ISBN: 978-0-387-09834-0
eBook Packages: MedicineReference Module Medicine